Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
22.90
+0.16 (0.70%)
At close: Apr 8, 2026, 4:00 PM EDT
22.90
0.00 (0.00%)
After-hours: Apr 8, 2026, 8:00 PM EDT

Pelthos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
77964---
Market Cap Growth
701.73%2376.40%----
Enterprise Value
93855---
Last Close Price
22.7431.006.41---
PS Ratio
4.545.70----
PB Ratio
1.892.46-1.42---
EV/Sales Ratio
5.555.06----
Debt / Equity Ratio
0.900.90-0.80-0.20-0.15-0.30
Net Debt / Equity Ratio
0.430.43-0.62-0.18-0.13-0.30
Net Debt / EBITDA Ratio
-0.58-0.58---0.30-
Net Debt / FCF Ratio
-0.74-0.74-0.29-1.19-0.31-0.69
Asset Turnover
0.260.26----
Quick Ratio
1.031.030.130.020.02-
Current Ratio
2.062.060.340.020.02-
Return on Equity (ROE)
-239.55%-239.55%----
Return on Assets (ROA)
-29.79%-29.79%-645.82%-5663.30%--
Return on Capital Employed (ROCE)
-30.10%-30.10%279.00%106.50%62.50%32.50%
Earnings Yield
-56.77%-45.27%-205.88%---
FCF Yield
-29.73%-23.71%-149.90%---
Buyback Yield / Dilution
-237.34%-237.34%-336.69%-193.25%--
Updated Mar 19, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q